老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neoleukin Therapeutics, Inc.

3.49
0.0000
成交量：- -
成交額：39.34萬
市值：3,279.87萬
市盈率：-1.14
高：3.49
開：3.49
低：3.49
收：3.49
52周最高：4.70
52周最低：1.90
股本：939.79萬
流通股本：544.90萬
量比：- -
換手率：- -
股息：- -
股息率：- -
每股收益(TTM):-3.0649
每股收益(LYR):-5.2115
淨資產收益率：-37.88%
總資產收益率：-18.70%
市淨率：0.44
市盈率(LYR):-0.67

資料載入中...

總覽公司新聞資訊公告
2020/03/20

重要事件披露

Current report, items 4.01 and 9.01
2020/03/12

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/12

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/03/10

重要事件披露

Current report, items 5.08 and 8.01
2020/02/25

重要事件披露

Current report, item 5.02
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2019/12/30

重要事件披露

Current report, item 1.01
2019/12/27

超過5%披露

General statement of acquisition of beneficial ownership
2019/12/27

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/20

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/19

重要事件披露

Current report, items 1.01, 3.02, 8.01, and 9.01
2019/12/17

重要事件披露

[Amend] Current report, item 9.01
2019/12/05

重要事件披露

Current report, items 7.01 and 9.01
2019/11/18

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/15

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/11/14

重要事件披露

Current report, items 5.07, 8.01, and 9.01
更多